November 3rd, 2017
Dr Frankie Rawson of the School of Pharmacy has been awarded almost £1m from the Engineering and Physical Sciences Research Council (EPSRC) to develop his research into bioelectronic technologies, which are set to transform healthcare.
Dr Rawson is investigating how bioelectronic devices will use electrochemical-based wireless technology to avoid invasive surgery, and also be applied to treat diseases such as cancer via the control of the body’s electrical signals.
He was awarded £950,798 to further his research by the EPSRC. Its Chief Executive Professor Philip Nelson said: “EPSRC’s Healthcare Technologies Challenge Awards are designed to equip the next generation of research leaders with the tools they need to tackle current and emerging health challenges facing society.”
Dr Rawson said: “We are on the brink of a new era of therapeutic intervention that relies on modulating the body’s cellular electrical signals by merging biology with electronics, termed bioelectronic therapeutics or electroceutics. With strong support from the University of Nottingham I am leading an international multidisciplinary team, consisting of engineers, physicists, biologists, chemists and clinicians, to develop a new class of technology that stands to make an impact on human health and well-being.”
Tags: Dr Frankie Rawson, Engineering and Physical Sciences Research Council, EPSRC, School of Pharmacy
Appraisal and Development Conversation (ADC) update: March 2023
The university has carried out a review of the Appraisal and Development Conversation (ADC) process, which […]
HEPI report: humanities in the UK today
The Higher Education Policy Institute, in collaboration with the Russell Group’s Pro Vice Chancellors and Deans […]